Ranbaxy Laboratories (LSE:RBXD) Market Cap : $3,163.7 Mil (As of May. 06, 2024)

View and export this data going back to . Start your Free Trial

What is Ranbaxy Laboratories Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Ranbaxy Laboratories's share price for the quarter that ended in Sep. 2014 was $10.24. Ranbaxy Laboratories's Shares Outstanding (EOP) for the quarter that ended in Sep. 2014 was 413.6 Mil. Therefore, Ranbaxy Laboratories's market cap for the quarter that ended in Sep. 2014 was $4,234.9 Mil.

Ranbaxy Laboratories's quarterly market cap declined from Dec. 2012 ($3,848.5 Mil) to Jun. 2013 ($2,277.4 Mil) but then increased from Jun. 2013 ($2,277.4 Mil) to Sep. 2014 ($4,234.9 Mil).

Ranbaxy Laboratories's annual market cap increased from Dec. 2009 ($4,886.7 Mil) to Dec. 2010 ($6,091.9 Mil) but then declined from Dec. 2010 ($6,091.9 Mil) to Dec. 2011 ($3,327.2 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Ranbaxy Laboratories's Enterprise Value for Today is $3,627.5 Mil.

Ranbaxy Laboratories Market Cap Historical Data

The historical data trend for Ranbaxy Laboratories's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ranbaxy Laboratories Market Cap Chart

Ranbaxy Laboratories Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Market Cap

Get a 7-Day Free Trial

4,886.69

6,091.94

3,327.21

Ranbaxy Laboratories Quarterly Data
	Dec11	Dec12	Jun13	Sep14
Market Cap	3,327.21	3,848.52	2,277.39	4,234.90

Competitive Comparison of Ranbaxy Laboratories's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Ranbaxy Laboratories's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ranbaxy Laboratories's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ranbaxy Laboratories's Market Cap distribution charts can be found below:

* The bar in red indicates where Ranbaxy Laboratories's Market Cap falls into.

Ranbaxy Laboratories Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Ranbaxy Laboratories's Market Cap for the fiscal year that ended in Dec. 2011 is calculated as

Market Cap (A: Dec. 2011 )	=	Share Price (A: Dec. 2011 )	*	Shares Outstanding (EOP) (A: Dec. 2011 )
	=	$7.895	*	421.432
	=	$3,327.2

Ranbaxy Laboratories's Market Cap for the quarter that ended in Sep. 2014 is calculated as

Market Cap (Q: Sep. 2014 )	=	Share Price (Q: Sep. 2014 )	*	Shares Outstanding (EOP) (Q: Sep. 2014 )
	=	$10.24	*	413.564
	=	$4,234.9

Ranbaxy Laboratories (LSE:RBXD) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Ranbaxy Laboratories Market Cap Related Terms

Thank you for viewing the detailed overview of Ranbaxy Laboratories's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Ranbaxy Laboratories (LSE:RBXD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ranbaxy Laboratories Ltd (LSE:RBXD) » Definitions » Market Cap

Traded in Other Exchanges

N/A

Address

Website

http://www.ranbaxy.com

Ranbaxy Laboratories Ltd., is an integrated international pharmaceuticals company. It markets, produces and distributes pharmaceuticals products.

Ranbaxy Laboratories (LSE:RBXD) Headlines

No Headlines